Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-597-3 | CAS number: 143-28-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
There is no information on the genetic toxicity of (Z)-octadec-9 -en-ol so key studies were chosen from studies on closely related linear or branched alcohols of similar chain length, including a study on an unsaturated alcohol. The choice of key study was based on reliability and similarity of chain length. The data available from standard in vitro and in vivo genetic toxicity assays for all related substances show no evidence of mutagenic potential.
Alcohols, C16-18 and C18-unsaturated, has been tested for mutagenicity to bacteria, in a study which was conducted according to the OECD TG 471, compliant with GLP. No evidence of a test-substance related increase in the number of revertants was observed with or without metabolic activation inSalmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537, or TA 1538 in the initial or the repeat experiments up to precipitation concentration. Appropriate positive and solvent controls were included and gave the expected results. It is concluded that the test substance is negative for mutagenicity to bacteria under the conditions of the test (Banduhn, 1989).
Docosan-1-ol has been tested in a valid study according to a protocol similar or equivalent to OECD TG 473 up to limit concentration of 20 µg/ml. No increase in the number of cells with aberrations was observed either with or without metabolic activation in Chinese hamster lung fibroblasts (V79). Appropriate positive, solvent and negative controls were included and gave the expected results. It is concluded that the test substance is negative for the induction of chromosome aberrations under the conditions of this study (Iglesias, 2002b).
Docosan-1-ol has been tested in a valid study according to a protocol similar to OECD TG 476. No statistically and biologically significant increase in the mutant frequency was observed when tested up to limit concentration in Chinese hamster fibroblasts (V79) with and without metabolic activation. Appropriate positive, solvent and negative controls were included and gave the expected results. It is concluded that the test substance is negative for mutagenicity to mammalian cells under the conditions of the test (Iglesias, 2002b).
Docosan-1-ol has been tested for the induction of micronuclei in mice according to a protocol similar to OECD TG 474. No evidence for a test substance induced increase in the incidence of micronucleated normochromatic erythrocytes in mice bone marrow. Appropriate positive and solvent controls were included and gave the expected results. It is concluded that the test substance does not cause damage to chromosomes under the conditions of the test (Iglesias, 2002b).
Octadecan-1-ol has been tested for the induction of micronuclei in mice according to a protocol similar to OECD TG 474. No evidence for a test substance induced increase in the incidence of micronucleated normochromatic erythrocytes in mice bone marrow. Appropriate positive and solvent controls were included and gave the expected results. It is concluded that the test substance does not cause damage to chromosomes under the conditions of the test (Iglesias, 2002b).
Discussion of trends in the Category of C6-24 linear and essentially-linear aliphatic alcohols:
The in vitro and in vivo data available for members of the category and supporting substances indicate that the C6-24 alcohols are not genotoxic. In addition, the category of LCAAs under consideration does not contain any structural elements that are of concern for potential mutagenic activity (Ashby and Tenant, 1991). Furthermore, primary LCAAs (linear and branched) in the range C1 to C5 do not have a mutagenic potential (Bevan, 2001; OECD SIDS butan-1-ol, 2001). Moreover, in a review by WHO-JECFA a series of 22 saturated aliphatic branched-chain primary LCAAs and the corresponding aldehydes and acids in the range C4 to C8 showed no activity in a battery of in vitro and in vivo mutagenicity tests (WHO, 1999). On this basis it is concluded that the category of LCAAs does not have a mutagenic potential and that read-across within the category can be justified. Where data gaps exist, the gap is filled by read-across from reliable evidence within the C6-24 Alcohols Category, where possible using interpolation between at least two reliable studies using higher and lower carbon number test substances.
It is concluded that the category C6-24 LCAAs do not have a genotoxic potential. and in vivo data available for members of the category and supporting substances indicate that the C6-24 alcohols are not genotoxic. In addition, the category of LCAAs under consideration does not contain any structural elements that are of concern for potential mutagenic activity (Ashby and Tenant, 1991). Furthermore, primary LCAAs (linear and branched) in the range C1 to C5 do not have a mutagenic potential (Bevan, 2001; OECD SIDS butan-1-ol, 2001). Moreover, in a review by WHO-JECFA a series of 22 saturated aliphatic branched-chain primary LCAAs and the corresponding aldehydes and acids in the range C4 to C8 showed no activity in a battery of in vitro and in vivo mutagenicity tests (WHO, 1998). On this basis it is concluded that the category of LCAAs does not have a mutagenic potential and that read-across within the category can be justified. Where data gaps exist, the gap is filled by read-across from reliable evidence within the C6-24 Alcohols Category, where possible using interpolation between at least two reliable studies using higher and lower carbon number test substances.
Conclusion:
The category C6-24 LCAAs do not have a genotoxic potential.
Genetic toxicity of LCAAs
|
CAS |
CHEMICAL NAME |
Bacterial mutagenicity |
Mammalian cytogenicity |
Mammalian mutagenicity |
In vivo studies |
||||
Result (Rel.) |
Reference |
Result (Rel.) |
Reference |
Result (Rel.) |
Reference |
Result (Rel.) |
Reference |
|||
C6 |
111-27-3 |
Hexan-1-ol |
Neg; (1) |
Henkel, 1990 |
|
|
|
|
|
|
C7, 8 and 9 |
|
Alcohols, C7-9 |
Neg. (1) |
Shell, 1996 |
|
|
|
|
|
|
C8 |
111-87-5 |
Octan-1-ol |
Neg; (2) |
Henkel, 1982a; HLS, 1996k |
|
|
|
|
|
|
C8 |
104-76-7 |
2-ethylhexan-1-ol Supporting Substance |
Neg; (2) |
Kirby, 1983 |
|
|
Neg; (2) |
Kirby, 1983 |
Neg; (2) |
MN; rodent dominant. Lethal |
C8-10 |
none |
Fatty alcohol blend (40.7% C8 and 55.3% C10) Supporting Substance |
Neg(2) |
Dillon, D.M., McCartney, M.A. (1992) |
(Putman, 1983; WHO, 1993) |
|
Neg (1) |
Cattanach, P., Riach, C. (1992) |
Neg (1) |
Micronucleus (Holstrom, M., Innes, D. (1992)) |
C10 |
112-30-1 |
Decan-1-ol |
Neg (4) 2 strains only |
(HLS, 1996l) |
|
|
|
|
|
|
C12 |
112-53-8 |
Dodecan-1-ol |
Neg. (1)l |
(Thomson, 1996a)Shimizu, 1985 |
|
|
|
|
Neg. (2) |
Micronucleus; (Banduhn, 1992) |
C12 and 13 |
75782-87-5 |
Alcohols, C12-13 |
Neg (2, >80% lin) |
Dean, 1980 |
|
|
|
|
|
|
C12 and 13 |
740817-83-8 |
Alcohols, C12-13-branched and linear |
Neg (1 50% lin), |
Sasol, 1998f |
Neg (1 (50% lin) |
Sasol, 1998 g |
|
|
|
|
C12 |
67762-25-8 |
C12-18 Alcohols, Type B Supporting |
Neg (2)Ames |
Henkel 1982c |
|
|
|
|
|
|
C 12-15 |
90604-40-3 |
Alcohols, C12-15-branched and linear |
Neg (1) |
Ballantyne, 1996 |
|
|
|
|
|
|
C14 |
112-72-1 |
Tetradecan-1-ol |
Neg (1) |
Thompson, 1996b |
|
|
|
|
|
|
C16 |
36653-82-4 |
Hexadecan-1-ol |
Neg (1) |
Thompson, 1996c |
|
|
|
|
|
|
Neg. (2) |
Henkel, 1981d |
|
|
|
|
|
|
|||
C16 |
68002-94-8 |
C16-18 and C18 Unsaturated Supporting |
Neg. Ames (2) |
Banduhn, 1989) |
|
|
|
|
|
|
C18 |
112-92-5 |
Octadecan-1-ol |
Neg (1) |
Thomson, 1996d |
Not required |
In vivo available |
|
|
Neg (2) MN |
Hachiya, 1982 |
Neg(2) |
Henkel, 1981f |
|||||||||
C18 |
97552-91-5 |
C18-22 Alcohol Supporting |
Neg. Ames (2) |
Banduhn 1995 |
|
|
|
|
|
|
C22 |
661-19-8 |
1-Docosanol |
Neg (2), |
Iglesias, 2002a, Thompson, 1997 |
Neg (2), |
Iglesias, 2002a |
Neg (2) |
Iglesias, 2002a |
Neg (2) |
Micronucleus Iglesias, 2002aª |
C24-32 |
|
D-002*** |
|
|
|
|
|
|
Neg (4) |
MN; Dom. Leth.Rodeiro 1998 |
Supporting substance |
* MN: Mouse bone marrow micronucleus test; Dom. Leth. Mouse Dominant Lethal test; UDS: Unscheduled DNA
Synthesis assay
** Tested in S. typhimurium TA 98 and TA100, only.
***Mixture of very long chain fatty alcohols from hydrolysed beeeswax
References:
Ashby, J., Tennant, R.W., 1991. Definitive relationships among chemical structure, carcinogenicity,
and mutagenicity for 301 chemicals tested by the US NTP. Mutation Research 257, 229–306.
WHO, 1999. Technical Report Series 884 Evaluation of certain food additives and contaminants. 49th
Report of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), Geneva.
Justification for selection of genetic toxicity endpoint
Conclusion based on the following assays: bacterial mutagenicity; in vitro cytogenicity; mammalian mutagenicity; in vivo micronucleus assays in analogue substances. The studies were conducted according to appropriate OECD guidelines or to similar protocols.
Short description of key information:
In vitro information:
Gene mutation (Bacterial reverse mutation assay / Ames test): the related substance C16-18 and C18 unsatd was negative with and without activation in S. typhimurium strains TA 98, TA100, TA1535, TA1537 and TA 1538 (OECD TG 471)
Cytogenicity in mammalian cells: the related substance Docosan-1-ol was negative with and without activation in Chinese hamster ovary cells (similar to OECD TG 473)
Mutagenicity in mammalian cells: the related substance Docosan-1-ol was negative with and without activation in Chinese hamster lung V79 cells (similar to OECD TG 476)
In vivo
Mouse micronucleus study: the related substances dodecanol and docosanol were negative in bone marrow (similar to OECD TG 474)
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.